Philips Medical Systems North America of Shelton, CT, has received Food and Drug Administration clearance for a new MRI upgrade package that includes high-end features such as cardiac scanning protocols and neuro imaging techniques. The package is
Philips Medical Systems North America of Shelton, CT, has received Food and Drug Administration clearance for a new MRI upgrade package that includes high-end features such as cardiac scanning protocols and neuro imaging techniques. The package is available on the companys Gyroscan NT line of magnets.
In the neuro imaging realm, the new package includes an option supporting diffusion, perfusion, and functional brain imaging, which can help in the early detection of stroke. On the cardiac side, the package enables a Gyroscan NT site to conduct cardiac MRI without purchasing additional hardware. One feature of the package, MotionTrak, enables users to control motion artifacts through gating and slice tracking. Other features of the new package include advancements in MR angiography, MR spectroscopy, and coil technology.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.